Little Cancer Risk from Fukushima

A new report from the World Health Organization predicts only very minimal increases in cancer risk for residents in the vicinity of the nuclear disaster.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Photo taken at the Fukushima Nuclear Power Plant in 1999WIKIMEDIA, AKIRA KOUCHIYAMAThe release of radioactive materials from the Fukushima Daiichi nuclear power plant 2 years ago this month is unlikely to cause a significant cancer burden, according to a 172-page report released yesterday (February 28) by the World Health Organization (WHO). While workers who were directly involved with the disaster may be at higher risk of leukemia, thyroid cancer, and all solid cancers, even those living near the plant should be safe, the WHO concluded.

“Outside the geographical areas most affected by radiation, even in locations within Fukushima prefecture, the predicted risks remain low and no observable increases in cancer above natural variation in baseline rates are anticipated,” the report’s summary read.

But not everyone’s mind is put at ease. “The WHO report shamelessly downplays the impact of early radioactive releases from the Fukushima disaster on people inside the 20 km evacuation zone who were not able to leave the area quickly,” Rianne Teule, Greenpeace International nuclear radiation expert, said in a statement. On the other hand, radiation biologist Kazuo Sakai of Japan's National Institute of Radiological Sciences told ScienceInsider that the report may actually overstate some of the risks by using preliminary data that may have overestimated radiation exposure. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
Image of a woman with her hands across her stomach. She has a look of discomfort on her face. There is a blown up image of her stomach next to her and it has colorful butterflies and gut bacteria all swarming within the gut.
November 2025, Issue 1

Why Do We Feel Butterflies in the Stomach?

These fluttering sensations are the brain’s reaction to certain emotions, which can be amplified or soothed by the gut’s own “bugs".

View this Issue
Olga Anczukow and Ryan Englander discuss how transcriptome splicing affects immune system function in lung cancer.

Long-Read RNA Sequencing Reveals a Regulatory Role for Splicing in Immunotherapy Responses

Pacific Biosciences logo
Research Roundtable: The Evolving World of Spatial Biology

Research Roundtable: The Evolving World of Spatial Biology

Conceptual cartoon image of gene editing technology

Exploring the State of the Art in Gene Editing Techniques

Bio-Rad
Conceptual image of a doctor holding a brain puzzle, representing Alzheimer's disease diagnosis.

Simplifying Early Alzheimer’s Disease Diagnosis with Blood Testing

fujirebio logo

Products

Labvantage Logo

LabVantage Solutions Awarded $22.3 Million U.S Customs and Border Protection Contract to Deliver Next-Generation Forensic LIMS

The Scientist Placeholder Image

Evosep Unveils Open Innovation Initiative to Expand Standardization in Proteomics

OGT logo

OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel